CIK: 1712069 - Address: C/O Lyell Immunopharma, Inc., 201 Haskins Way, South San Franicsco, CA 94080
26 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/20/23 16:36
1/18/23
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-3426.890-10354D
1/5/23 17:20
1/4/23
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-7526.900-3-1356D
10/20/22 16:51
10/18/22
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-4925.200-2-1358D
10/6/22 16:26
10/4/22
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-9024.400-4-1360D
8/16/22 17:01
8/15/22
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-56918.230-31-8364D
7/20/22 16:38
7/18/22
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-2512.870-2-1270D
7/8/22 16:08
7/6/22
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-5013.400-4-1272D
4/21/22 16:28
4/19/22
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-8410.450-8-3276D
4/7/22 16:19
4/5/22
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-3413.780-2-1173D
1/6/22 16:46
1/4/22
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-7316.270-4-2175D
10/7/21 16:02
10/5/21
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-14421.620-7-4180D
7/13/21 16:21
7/9/21
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-15021.520-7-4187D
4/8/21 16:57
4/6/21
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-20218.620-11-7135D
3/17/21 16:06
3/15/21
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.M.d2337.7803026146D
3/17/21 16:06
3/15/21
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S.d-75225.070-30-17146D
12/22/20 16:33
12/18/20
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.M.d787.780107146D
12/22/20 16:33
12/18/20
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S.d-25425.410-10-6146D
12/11/20 16:22
12/9/20
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.M.dm1567.7802016146D
12/11/20 16:22
12/9/20
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S.dm-50425.190-20-12146D
9/2/20 16:47
8/31/20
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.M.d2087.7802722146D
9/2/20 16:47
8/31/20
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S.d-53520.050-27-15146D
8/28/20 17:41
8/26/20
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.M.dm217.78032146D
8/28/20 17:41
8/26/20
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S.dm-5420.020-3-2146D
8/21/20 17:04
8/19/20
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.M.d57.78010146D
8/21/20 17:04
8/19/20
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S.d-1220.000-10146D
12/30/19 19:14
12/30/19
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsLang MatthewCAOGC,Corp.S-29615.550-19-3535D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact